DaVita Inc. (DVA) Financial Statements
Historical financial data — 41 statements covering FY2016–FY2025
DaVita is one of the largest providers of dialysis services in the United States, boasting a market share of about 35%. The firm operates over 3,200 facilities worldwide, mostly in the US, and trea...
DaVita Inc.'s revenue increased 6.5% year over year, from $12.82B to $13.64B.
Net income decreased 20.2% over the same period, from $936.3M to $746.8M.
Over the 9-year period from FY2016 to FY2025, revenue declined by 7% in total.
Total debt increased by 8.7% to $10.27B.
Operating cash flow declined 6.7% to $1.89B.
DaVita Inc. maintains a moderate net profit margin of 5.5%.
Recent Financial Statements
| Period | Revenue | Net Income | Gross Profit | EBIT | Op. Cash Flow | Total Assets | Total Debt | Equity |
|---|---|---|---|---|---|---|---|---|
| Q3 FY2023 | $8.99B+53.1% | $540.9M | $1.21B | $1.21B | $1.57B | $16.93B | $8.39B | $1.20B |
| Q1 FY2024 | $3.07B-65.9% | $239.6M | $483.8M | $483.8M | $-134.8M | $17.43B | $9.13B | $926.0M |
| Q2 FY2024 | $6.26B+103.8% | $462.3M | $990.2M | $990.2M | $664.0M | $17.03B | $8.99B | $632.9M |
| Q3 FY2024 | $9.52B+52.2% | $677.0M | $1.53B | $1.53B | $1.47B | $17.50B | $9.56B | $386.7M |
| Q1 FY2025 | $3.22B-66.1% | $162.9M | $438.9M | $438.9M | $180.0M | $17.12B | $9.74B | $-267.1M |
| Q2 FY2025 | $6.60B+104.8% | $362.3M | $976.8M | $976.8M | $504.2M | $17.49B | $10.26B | $-369.6M |
| Q3 FY2025 | $10.02B+51.8% | $512.6M | $1.48B | $1.48B | $1.35B | $17.56B | $10.25B | $-571.9M |
| Q1 FY2026 | $3.42B-65.9% | $197.5M | $481.9M | $481.9M | $320.8M | $17.50B | $10.63B | $-755.5M |
Balance Sheet Summary (Latest Period)
Total Assets
$17.48B
Total Liabilities
$16.32B
Total Equity
$-651.1M
Cash & Equivalents
$700.7M
Total Debt
$10.27B
Current Assets
$4.06B
Current Liabilities
$3.14B
Retained Earnings
$-328.4M